Xlife Sciences AG: Xlife Sciences takes stake in palleos healthcare
Xlife Sciences AG / Key word(s): Investment
Xlife Sciences AG (XLS DE, Xetra) acquires a 50% stake in palleos healthcare GmbH, Wiesbaden, Germany. Based on an approximate valuation of the company at EUR 10.0 million, the acquisition price is EUR 4.0 million and 40,000 shares of Xlife Sciences AG. Specific milestones have been agreed upon for the final settlement date and acquisition price, specific milestones have been agreed upon. The notarization of the share purchase and transfer agreement as well as the capital increase was executed today.
About palleos healthcare GmbH
About Xlife Sciences AG
Xlife Sciences AG (XLS DE, Xetra) is a Swiss company with focus on investing in promising technologies in the life science industry. Xlife Sciences AG is building the bridge from research and development to healthcare markets. Together with industrial partners or universities, Xlife Sciences AG leads projects through the proof-of-concept phase after an invention disclosure or start-up. Subsequently, the firm focuses on out-licensing or selling the company, often with a combination of a strategic partnership. Xlife Sciences AG offers its investors direct access to the further development of innovative and future-oriented technologies at a very early stage.
05-Aug-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||Xlife Sciences AG|
|Phone:||0041 44 385 84 60|
|Listed:||Regulated Unofficial Market in Frankfurt, Munich|
|EQS News ID:||1110647|
|End of Announcement||DGAP News Service|